Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).
Johnson PW, Radford JA, Cullen MH, Sydes MR, Walewski J, Jack AS, MacLennan KA, Stenning SP, Clawson S, Smith P, Ryder D, Hancock BW; United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). Johnson PW, et al. Among authors: ryder d. J Clin Oncol. 2005 Dec 20;23(36):9208-18. doi: 10.1200/JCO.2005.03.2151. Epub 2005 Nov 28. J Clin Oncol. 2005. PMID: 16314615 Clinical Trial.
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.
Franklin J, Pluetschow A, Paus M, Specht L, Anselmo AP, Aviles A, Biti G, Bogatyreva T, Bonadonna G, Brillant C, Cavalieri E, Diehl V, Eghbali H, Fermé C, Henry-Amar M, Hoppe R, Howard S, Meyer R, Niedzwiecki D, Pavlovsky S, Radford J, Raemaekers J, Ryder D, Schiller P, Shakhtarina S, Valagussa P, Wilimas J, Yahalom J. Franklin J, et al. Among authors: ryder d. Ann Oncol. 2006 Dec;17(12):1749-60. doi: 10.1093/annonc/mdl302. Epub 2006 Sep 19. Ann Oncol. 2006. PMID: 16984979 Free article.
Reply to G. Zalcman et al.
Bayman N, Clive A, Maskell N, Ryder D, Taylor H, Faivre-Finn C. Bayman N, et al. Among authors: ryder d. J Clin Oncol. 2019 Oct 10;37(29):2694-2695. doi: 10.1200/JCO.19.01520. Epub 2019 Aug 22. J Clin Oncol. 2019. PMID: 31437093 No abstract available.
VAD chemotherapy as remission induction for multiple myeloma.
Anderson H, Scarffe JH, Ranson M, Young R, Wieringa GS, Morgenstern GR, Fitzsimmons L, Ryder D. Anderson H, et al. Among authors: ryder d. Br J Cancer. 1995 Feb;71(2):326-30. doi: 10.1038/bjc.1995.65. Br J Cancer. 1995. PMID: 7841049 Free PMC article.
Autologous peripheral blood stem cell transplantation in first remission adult acute myeloid leukaemia--an intention to treat analysis and comparison of outcome using a predictive model based on the MRC AML10 cohort.
Ewing JC, Robertson JD, Kell WJ, Burnett AK, Ryder D, Chang J, Morgenstern GR, Scarffe JH, Chopra R. Ewing JC, et al. Among authors: ryder d. Hematology. 2003 Apr;8(2):83-90. doi: 10.1080/1024533031000090793. Hematology. 2003. PMID: 12745657 Free article.
Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
Eustace A, Irlam JJ, Taylor J, Denley H, Agrawal S, Choudhury A, Ryder D, Ord JJ, Harris AL, Rojas AM, Hoskin PJ, West CM. Eustace A, et al. Among authors: ryder d. Radiother Oncol. 2013 Jul;108(1):40-7. doi: 10.1016/j.radonc.2013.05.017. Epub 2013 Jun 14. Radiother Oncol. 2013. PMID: 23773411 Free PMC article. Clinical Trial.
152 results